MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-12-2026
GBS EPS Ratio 2011-2026 | GBS
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio GBS
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2 | -6.38 | -127 | -11.3 | -0.68 | -0.37 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.37 | -127 | -24.6 |
Quarterly EPS Ratio GBS
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.82 | -0.35 | - | -0.44 | -4.96 | -0.7 | - | -1.43 | -2.07 | -12.5 | - | -68.7 | -5.56 | - | -1.97 | -1.79 | -4.65 | -0.64 | -6.77 | -0.27 | -0.23 | -0.12 | -0.23 | -0.01 | -0.22 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.01 | -68.7 | -5.54 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-2.81 | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-0.51 | $ 3.89 | -0.77 % | $ 145 M |  France |
 |
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-0.96 | $ 12.72 | 1.27 % | $ 1.91 B | USA |
 |
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
-0.34 | $ 31.16 | 0.71 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B | USA |
 |
InMode Ltd.
INMD
|
1.45 | $ 13.79 | 2.53 % | $ 891 M |  Israel |
 |
Aziyo Biologics
AZYO
|
1.29 | - | 1.37 % | $ 20.5 M | USA |
 |
Aethlon Medical
AEMD
|
-8.58 | $ 2.21 | -1.34 % | $ 3.45 M | USA |
 |
Bio-Rad Laboratories
BIO
|
-25.6 | $ 265.0 | -1.12 % | $ 7.48 B | USA |
 |
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-0.91 | $ 2.51 | 2.03 % | $ 147 M | Israel |
 |
Bruker Corporation
BRKR
|
0.76 | $ 33.63 | -1.18 % | $ 5.01 K | USA |
 |
BioSig Technologies
BSGM
|
-0.75 | - | 37.08 % | $ 85.7 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-0.52 | $ 10.08 | -3.72 % | $ 1.36 B | USA |
 |
Profound Medical Corp.
PROF
|
1.5 | $ 5.16 | -5.67 % | $ 180 M |  Canada |
 |
Boston Scientific Corporation
BSX
|
1.96 | $ 69.89 | -1.95 % | $ 103 B | USA |
 |
Butterfly Network
BFLY
|
-0.34 | $ 3.97 | 0.51 % | $ 840 M | USA |
 |
Align Technology
ALGN
|
5.63 | $ 176.25 | 2.23 % | $ 13.2 B | USA |
 |
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-0.9 | $ 9.18 | -4.42 % | $ 260 M | USA |
 |
CONMED Corporation
CNMD
|
1.52 | $ 36.8 | 0.25 % | $ 1.14 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-0.38 | $ 0.64 | -1.86 % | $ 34.8 M | USA |
 |
Cutera
CUTR
|
-2.87 | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
0.08 | $ 9.34 | -0.43 % | $ 335 M | USA |
 |
Cardiovascular Systems
CSII
|
-0.94 | - | 0.15 % | $ 844 M | USA |
 |
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
0.89 | $ 23.49 | 1.38 % | $ 199 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-1.72 | $ 65.53 | 0.05 % | $ 1.94 B |  Costa-rica |
 |
Eargo
EAR
|
-39.7 | - | - | $ 10.2 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.84 | $ 82.46 | -0.18 % | $ 48.2 B | USA |
 |
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
1.78 | $ 18.39 | -0.27 % | $ 121 M | USA |
 |
Globus Medical
GMED
|
3.98 | $ 86.3 | -0.32 % | $ 11.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
-14.6 | $ 2.11 | 1.93 % | $ 1.28 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-0.09 | $ 8.9 | - | $ 685 M | USA |